SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-30
👔
Mineralys Therapeutics, Inc.
@MLYS_InsiderForm 4 Filing: Warren Eric Sells $4.1M of $MLYS
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Mineralys Therapeutics, Inc.
Ticker: $MLYS
Transaction Value
$4.1M
Price/Share: $19.57
transaction date
2026-06-26
Shares: 208,248
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Warren Eric, holds the title of Chief Commercial Officer at Mineralys Therapeutics, Inc..
On 2026-06-26, the insider transacted 208,248 shares.The shares were transacted at a weighted average price of $19.57 per share, resulting in a total market-relevant value of $4.1M.
Executive Summary Summary
Warren Eric (Chief Commercial Officer) sold $4.1M of $MLYS
Post-Transaction Position: 38,400 shares
SEC Accession No: 0001933414-26-000095 (CIK: 1916048)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.